Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Genital Herpes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Not applicableStudy completedNCT05500053
What this trial is testing

The Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Who this might be right for
Genital HerpesPatient Engagement
Rational Vaccines Inc 68
Not applicableStudy completedNCT04950712
What this trial is testing

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Who this might be right for
Herpes Genitalis
GlaxoSmithKline 537
Not applicableStudy completedNCT02053142
What this trial is testing

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

Who this might be right for
Ulcers of Female Genital Organs
University of North Carolina, Chapel Hill 74
Not applicableStudy completedNCT01154543
What this trial is testing

Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes

Who this might be right for
HIV PositiveHerpes Simplex, Genital
Holdsworth House Medical Practice 42
Post-approval studies (Phase 4)Study completedNCT00219310
What this trial is testing

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Who this might be right for
Recurrent Genital Herpes (RGH)
Novartis
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Testing effectiveness (Phase 2)Study completedNCT04165122
What this trial is testing

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Who this might be right for
Herpes Genitalis
Heidelberg ImmunoTherapeutics GmbH 122
Post-approval studies (Phase 4)Study completedNCT00477334
What this trial is testing

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Who this might be right for
Genital Herpes
Novartis 463
Post-approval studies (Phase 4)Ended earlyNCT04235322
What this trial is testing

Study of 2LHERP® in Genital Herpes Infections

Who this might be right for
Herpes Simplex, Genital
Labo'Life 6
Not applicableStudy completedNCT00002000
What this trial is testing

Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

Who this might be right for
Herpes SimplexHIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Large-scale testing (Phase 3)UnknownNCT00005663
What this trial is testing

Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Who this might be right for
Herpes SimplexHIV InfectionsHerpes Genitalis
Glaxo Wellcome
Post-approval studies (Phase 4)Study completedNCT00116844
What this trial is testing

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Who this might be right for
Infections, Herpesviridae
GlaxoSmithKline 73
Early research (Phase 1)Ended earlyNCT04222985
What this trial is testing

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

Who this might be right for
Genital Herpes
Sanofi Pasteur, a Sanofi Company 24
Early research (Phase 1)UnknownNCT05393440
What this trial is testing

First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Zhongnan Hospital 18